Palliating delirium in patients with cancer

The Lancet Oncology

Volumn 10, Issue 2, 2009, Pages 164-172

  Caraceni, Augusto ^a   Simonetti, Fabio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; CORTICOSTEROID; DEXMEDETOMIDINE; FENTANYL; HALOPERIDOL; LEVOMEPROMAZINE; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; PROMAZINE; PROMETHAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE;

ANTICHOLINERGIC SYNDROME; ATTENTION; BONE METASTASIS; BONE PAIN; CANCER PALLIATIVE THERAPY; CAREGIVER BURDEN; CATATONIA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONSCIOUSNESS; DELIRIUM; DELIRIUM TREMENS; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG ABSORPTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; FAMILY; HEART ARRHYTHMIA; HUMAN; HYPERPYREXIA; INCIDENCE; LOW DRUG DOSE; MINI MENTAL STATE EXAMINATION; MUSCLE RIGIDITY; NASOPHARYNX CANCER; NEUROLEPTIC MALIGNANT SYNDROME; PATHOPHYSIOLOGY; PNEUMONIA; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RECOMMENDED DRUG DOSE; REPEATED DRUG DOSE; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

DELIRIUM; HUMANS; NEOPLASMS; PALLIATIVE CARE; RISK FACTORS;

EID: 58749103170     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(09)70018-X     Document Type: Review

References (75)

1. Clouston P.D., De Angelis L., and Posner J.B. The spectrum of neurological disease in patients with systemic cancer. Ann Neurol 31 (1992) 268-273
2. Francis J., Martin D., and Kapoor W.N. A prospective study of delirium in hospitalized elderly. JAMA 263 (1990) 1097-1101
3. Levkoff S.E., Evans D.A., Lipzin B., et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med 152 (1992) 334-340
4. Inouye S.K., Viscoli C.M., Horwitz R.I., Hurst L.D., and Tinetti M.E. A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 119 (1993) 474-481
5. Inouye S.K., and Charpentier P.A. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 275 (1996) 852-857
6. Ljubisavjevic V., and Kelly B. Risk factors for development of delirium among oncology patients. Gen Hosp Psychiatry 25 (2003) 345-352
7. Gaudreau J., Gagnon P., Roy M., and Tremblay A. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 23 (2005) 6712-6718
8. Minagawa H., Yosuke U., Yamawaki S., and Ishitani K. Psychiatric morbidity in terminally ill cancer patients. Cancer 78 (1996) 1131-1137
9. Lawlor P.G., Gagnon B., Mancini I.L., et al. Occurrence, causes and outcome of delirium in patients with advanced cancer. Arch Intern Med 160 (2000) 786-794
10. Caraceni A., Nanni O., Maltoni M., et al. The impact of delirium on the short-term prognosis of advanced cancer patients. Cancer 89 (2000) 1145-1148
11. Massie M.J., Holland J.C., and Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 140 (1983) 1048-1050
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. Text revision. DSM IV-TR (2000), American Psychiatric Press, Washington
13. Zeman A. Consciousness. Brain 124 (2001) 1263-1289
14. Giacino J.P. Disorders of consciousness: differential diagnosis and neuropathologic features. Semin Neurol 17 (1997) 105-111
15. Posner J., Saper C.B., and Schiff N.D. Plum and Posner's diagnosis of stupor and coma (2007), Oxford University Press, Oxford
16. Baht R., and Rockwood K. Delirium as a disorder of consciousness. J Neurol Neurosurg Psychiatry 78 (2007) 1167-1170
17. Hart R., Levenson J., Sessler C., Best A., Schwartz S., and Rutherford L. Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics 37 (1996) 533-546
18. Meagher D.J., Moran M., Bangaru R., et al. Phenomenology of delirium. Assessment of 100 adult cases using standardized measures. Br J Psychiatry 190 (2007) 135-141
19. Lipowski Z.J. Delirium: acute confusional states (1990), Oxford University Press, New York
20. Liptzin B., and Levkoff S.E. An empirical study of delirium subtypes. Br J Psychiatry 161 (1992) 843-845
21. Farrell K.R., and Ganzini L. Misdiagnosing delirium as depression in medically ill elderly patients. Arch Intern Med 155 (1995) 2459-2464
22. Trzepacz P.T. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord 10 (1999) 330-334
23. Lindesay J., Rockwood K., and Macdonald A. Delirium in old age (2002), Oxford University Press, Oxford
24. Caraceni A., and Grassi L. Delirium: acute confusional states in palliative medicine (2003), Oxford University Press, Oxford
25. Rudolph J., Salow M., Angelini M., and McGlinchey R. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 168 (2008) 508-513
26. Inouye S.K., Bogardus S.T., Charpentier P.A., et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 340 (1999) 669-676
27. Inouye S.K., Zhang Y., Jones R., Kiely D.K., Yang F., and Marcantonio E. Risk factors for delirium at discharge. Development and validation of a predictive model. Arch Intern Med 167 (2007) 1406-1413
28. Fayers P.M., Hjermstadt M., Ranhoff A., et al. Which Mini-mental State Exam items can be used to screen for delirium and cognitive impairment?. J Pain Symptom Manage 30 (2005) 41-50
29. Trzepacz P.T., Mittal D., Torres R., Kanary K., Norton J., and Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the Delirium Rating Scale and the Cognitive Test for Delirium. J Neuropsychiatry Clin Neurosci 13 (2001) 229-242
30. Breitbart W., Rosenfeld B., Roth A., Smith M.J., Cohen K., and Passik S. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 13 (1997) 128-137
31. Wei L., Fearing M., Sternberg E., and Inouye S.K. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc 56 (2008) 823-830
32. Gaudreau J., Gagnon P., Harel F., Tremblay A., and Roy M. Fast, systematic and continuous delirium assessment in hospitalized patients: the Nursing Delirium Screening Scale. J Pain Symptom Manage 29 (2005) 368-375
33. Fick D., Agostini J., and Inouye S. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc 50 (2002) 1723-1732
34. Flood K.L., Carrol M.B., Le C.V., Ball L., Esker D.A., and Carr D.B. Geriatric syndromes in elderly patients admitted to an oncology-acute care for elders unit. J Clin Oncol 24 (2006) 2298-2303
35. Towne A.R., Waterhouse E.J., Boggs J.G., et al. Prevalence of non-convulsive status epilepticus in comatose patients. Neurology 54 (2000) 340-345
36. Taylor M.A., and Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 160 (2003) 1233-1241
37. Tuma R., and DeAngelis L.M. Altered mental status in patients with cancer. Arch Neurol 57 (2000) 1727-1731
38. Dalmau J., and Rosenfeld M.R. Paraneoplastic syndromes of the CNS. Lancet Neurol 7 (2008) 327-340
39. Gorniak R., Young G., Wiese D., Marty F., and Schwartz R. MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogenic hematopoietic stem-cell transplantation. Am J Neuroradiol 27 (2006) 887-891
40. Vaughn C., Zhang L., and Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep 10 (2008) 86-91
41. Weitzener M.A., Olofson S.M., and Forman A.D. Patients with malignant meningitis presenting with neuropsychiatric manifestations. Cancer 76 (1995) 1804-1808
42. Gagnon P.R. Treatment of delirium in supportive and palliative care. Curr Opin Support Palliat Care 2 (2008) 60-66
43. American Psychiatric Association. Practice guidelines for the treatment of patients with delirium. Am J Psychiatry 156 5 suppl (1999) 1-20
44. Casarett D., and Inouye S. Diagnosis and management of delirium near the end of life. Ann Intern Med 135 (2001) 32-42
45. Canadian Coalition for Seniors' Mental Health. National guidelines for seniors' mental health: the assessment and treatment of delirium. http://www.ccsmh.ca/en/guidelinesusers.cfm (accessed Nov 3, 2008).
46. Lonergan E., Britton A., and Wyller T. Antipsychotics for delirium. Cochrane Database of Syst Rev 2 (2007) CD005594.
47. Seitz D., Gill S., and van Zyl L. Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry 68 (2007) 11-21
48. Lacasse H., Perreault M., and Williamson D. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 40 (2006) 1966-1973
49. Jackson K., and Lipman A. Drug therapy for delirium in terminally ill patients. Cochrane Database of Syst Rev 2 (2004) CD004770.
50. Mayo-Smith M.F., Beecher L., Fischer T., et al. Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164 (2004) 1405-1412
51. Pandharipande P., Shintay A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care patients. Anesthesiology 104 (2006) 21-26
52. Breitbart W., Marotta R., Platt M.M., Weisman H., Derevenco M., and Grau C. A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153 (1996) 231-237
53. Huf G., Coutinho E., Adams C., and for the TREC Collaborative Group. Rapid tranquillisation in psychiatric emergency settings in Brazil: pragmatic randomized controlled trial of intramuscular haloperidol versus intramuscular haloperidol plus promathazine. BMJ 335 (2007) 869-872
54. Akechi T., Uchitomi Y., Okamura H., et al. Usage of haloperidol for delirium in cancer patients. Support Care Cancer 4 (1996) 390-392
55. Olofson S.M., Weitzener M.A., Valentine A.D., Baile W.F., and Meyers C.A. A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4 (1996) 351-357
56. Stiefel F., Fainsinger R., and Bruera E. Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 7 (1992) 94-98
57. Breitbart W., Tremblay A., and Gibson C. An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43 (2002) 175-182
58. Schwartz T.L., and Masand P. Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry 2 (2000) 10-12
59. Sasaki Y., Matsuyama T., Inoue S., et al. A prospective, open label, flexible-dose study of quetiapine in the treatment of delirium. J Clin Psychiatry 64 (2003) 1316-1321
60. Oliver O.J. The use of methotrimeprazine in terminal care. Br J Clin Pract 39 (1985) 339-340
61. Green B., Pettit T., Faith L., and Seaton K. Focus on levomepromazine. Curr Med Res Opin 20 (2004) 1877-1881
62. Preskorn S.H. Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions. J Psychiatr Pract 9 (2003) 376-384
63. Alldredge B. Seizures risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 53 suppl 2 (1999) S68-S75
64. Mirski M., and Hemstreet M. Critical care sedation for neuroscience patients. J Neurol Sci 261 (2007) 16-34
65. Viganò A., Dorgan M., Buckingham J., Bruera E., and Suarez-Almazor M.E. Survival prediction in terminal cancer patients: a systematic review of the literature. Palliat Med 11 (2001) 363-374
66. Sykes N., and Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 4 (2003) 312-318
67. Morita T., Chinone Y., Ikenaga M., et al. Efficacy and safety of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage 30 (2005) 320-328
68. Morita T., Chinone Y., Ikenaga M., et al. Ethical validity of palliative sedation therapy: a multicenter, prospective, observational study conducted on specialized palliative care units in Japan. J Pain Symptom Manage 30 (2005) 308-319
69. De Graef A., and Dean M. Palliative sedation in the last weeks of life: a literature review and recommednation for standards. J Palliat Med 10 (2007) 67-85
70. Matersvedt L.J., Clark D., Ellershaw J., et al. Euthanasia and physician-assisted suicide: a view from an EAPC ethics task force. Palliat Med 17 (2003) 97-101
71. Brajtman S. The impact on the family of terminal restlessness and its management. Palliat Med 17 (2003) 454-460
72. Breitbart W., Gibson C., and Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouse/caregivers and nurses. Psychosomatics 43 (2002) 183-194
73. Morita T., Akechi T., Ikenaga M., et al. Terminal delirium: recommendations from bereaved families. J Pain Symptom Manage 34 (2007) 579-589
74. Morita T., Hirai K., Sakaguchi Y., Tsuneto S., and Shima Y. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics 45 (2004) 2107-2113
75. Buss M., Vaderwerker L., Inouye S.K., Zhang B., Block S., and Prigeson H. Association between caregiver-perceived delirium in patients with cancer and generalized anxiety in their caregivers. J Palliat Med 10 (2007) 1083-1092